BioLASCO Taiwan Co., Ltd. announced board changes. Title and name of the previous position holder: Director: Chen-Chung Chen, Li-Chu Wu, Chun-Wei Chen, and Wei-Ming Liu. Independent Director: Ming-Chieh Chen, Xing-hua Su, and Han-Tan Cheng.

Resume of the previous position holder: Director: Chen-Chung Chen /BioLASCO Taiwan Co., Ltd., Chairperson, Li-Chu Wu /Tseng Hsiang Life Science Ltd., Vice Chairperson, Chun-Wei Chen /Nobel Biotech Corporation., Director, Wei-Ming Liu /Proceed Investment Co., Ltd., Chairperson. Independent Director: Ming-Chieh Chen. /AmTrust Investment Consulting Corp., Vice President, Xing-hua Su /We Tec International CPAs., Partner Accountant, Han-Tan Cheng /Awesome Business Model Innovation Co., Ltd., Chairperson.

5.Title and name of the new position holder: Director: Chen-Chung Chen, Li-Chu Wu, Chun-Wei Chen, and Wei-Ming Liu. Independent Director: Ming-Chieh Chen, Han-Tan Cheng, and Feng-Ji Cheng. Resume of the new position holder: Director: Chen-Chung Chen /BioLASCO Taiwan Co., Ltd., Chairperson, Li-Chu Wu /Tseng Hsiang Life Science Ltd., Vice Chairperson, Chun-Wei Chen /Nobel Biotech Corporation., Director, Wei-Ming Liu /Proceed Investment Co., Ltd., Chairperson.

Independent Director: Ming-Chieh Chen. /AmTrust Investment Consulting Corp., Vice President. Han-Tan Cheng /Awesome Business Model Innovation Co., Ltd., Chairperson.

Feng-Ji Cheng /Pharmacology Discovery Services Taiwan, Ltd., and Eurofins Panlabs Discovery Services Taiwan, Ltd., Former Chairperson. Effective date of the new appointment: June 9, 2023.